Medical Institution Bankruptcies Exceed 40 for Second Consecutive Year, Total Liabilities Reach 25.372 Billion Yen, the Largest in 10 Years – @DIME

This news highlights the harsh management environment faced by medical institutions once again. In particular, the fact that total liabilities have reached the highest level in the past 10 years suggests not just individual management failures, but structural issues within the industry as a whole. It indicates a situation where stagnant medical fee increases, rising drug and personnel costs, and the burden of investment in expensive medical equipment are squeezing profitability for many medical institutions.

Under these circumstances, M&A and business succession for medical institutions take on a more strategic meaning, going beyond a short-term perspective of merely "selling" or "buying." To avoid the worst-case scenario of bankruptcy and ensure the continuity of regional medical care, early business succession before management deteriorates is extremely important. To maximize the unique benefits of M&A, such as releasing personal guarantees of management, maintaining staff employment, and inheriting long-cultivated patient bases, it is essential to proceed with planning in cooperation with experts while the financial situation is still sound.

Managers and potential successors of medical institutions should use this news as an opportunity to objectively reassess their own institution's management status and consider business succession options early on. Early consultation broadens the range of business succession options and increases the likelihood of achieving succession under more favorable terms.